TSPO and Parkinson disease: Also, the authors stated that since the specific binding of this radioligand in the cerebellum is not negligible, the latter cannot be used as a reference region for TSPO quantification as it may hide the effects of TSPO overexpression in certain pathological conditions, including PD [23].